Screening in Oculopharyngeal Muscular Dystrophy



Status:Recruiting
Conditions:Neurology
Therapuetic Areas:Neurology
Healthy:No
Age Range:18 - 80
Updated:6/27/2018
Start Date:October 2016
End Date:June 2019
Contact:Kelby Magennis, MPH
Email:kmagennis@phhp.ufl.edu
Phone:352-273-8632

Use our guide to learn which trials are right for you!

Determination of Accurate Screening Tools for Dysphagia in Oculopharyngeal Muscular Dystrophy

Oculopharyngeal muscular dystrophy (OPMD) is a rare myopathic disease that results in
progressive degeneration of the oral and pharyngeal muscular, resulting in severe dysphagia
and dysarthria. OPMD is considered a rare disease; therefore, limited research is available
on the natural progression of the disease or the utility of biomarkers to identify swallowing
impairment. The aim of this study is:

1. To identify accurate, reliable and non-invasive clinical markers of swallowing
impairment

2. To determine the discriminate ability of these markers to identify impairments in
swallow safety and swallowing efficiency.

Participants will be recruited from the Neurology clinic at the University of Florida. The
single evaluation will occur in the PIs research laboratory at the University of Florida,
Gainesville, Florida.

Inclusion Criteria:

- diagnosis of oculopharyngeal muscular dystrophy

- no allergies to barium or capsaicin,

- no tracheotomy or mechanical ventilation

- no significant concurrent respiratory disease (e.g., COPD).

Exclusion Criteria:

- Pregnant Women
We found this trial at
1
site
Gainesville, Florida 32610
(352) 392-3261
University of Florida The University of Florida (UF) is a major, public, comprehensive, land-grant, research...
?
mi
from
Gainesville, FL
Click here to add this to my saved trials